Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
producing a reaction at the benzodiazepine site
Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity
Chemical Name: N-(3-cyclobutyl-1H-pyrazol-5-yl)-2-{4-[(5-{[2-(2
Formula: C16H14F3N5O
Tafamidis Catalog No.:M8543-10 producing a reaction at theTafamidis, Tafamidis, also known as Fx 1006 or PF 06291826, is a drug for the amelioration of transthyretin related hereditary amyloidosis (also familial amyloid polyneuropathy, or FAP), a rare but deadly neurodegenerative disease. The drug was approved by the European Medicines Agency in November 2011 and by the Japanese Pharmaceuticals and Medical Devices Agency in September 2013. Tafamidis functions by kinetic stabilization of the correctly folded